Drug dis

New drugs for Old: Heparin and its mimetics

  • Chair(s):

    Prof. Clive Page,
    Director, Sackler Institute of Pulmonary Pharmacology,King's College London, London, United Kingdom

    Dr. John Hogwood
    Senior Scientist,National Institute for Biological Standards and Control, Potters Bar, United Kingdom

  • Session description:

    Nebulised heparin for the treatment of respiratory diseases
    Professor Janis Shute
    Professor of Respiratory Pharmacology, University of Portsmouth, Portsmouth, United Kingdom

    Prospective medical applications for sulfated polysaccharides of marine origin
    Professor Paulo Mourão
    Professor of Medical Biochemistry, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil

    Recent Progress in Recombinant Heparin
    Dr Charles Glass
    President, TEGA Therapeutics Inc. , San Diego, The United States of America

    Non-anticoagulant heparins as potential anti-inflammatory and anti-complementary agents
    Dr John Hogwood
    Senior Scientist, National Institute for Biological Standards and Control, Potters Bar, United Kingdom

    Synthetic heparan sulfate mimetics
    Professor Deirdre Coombe
    Head of Molecular Immunology Laboratory, Curtin University, Perth, Australia

  • 00

    days

  • 00

    hours

  • 00

    minutes

  • 00

    seconds

Date

06 Jul 2023

Time

4:05 pm - 5:50 pm

Speakers

Leave A Comment

Go to Top